ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

FGEN FibroGen Inc

1.14
-0.03 (-2.56%)
시간외 단일가
최종 업데이트: 21:41:03
15분 지연
기업명 주식 심볼 시장 주식 타입
FibroGen Inc FGEN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.03 -2.56% 1.14 21:41:03
개장가 저가 고가 종가 전일 종가
1.17
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
29/04/202420:00GLOBEFibroGen to Report First Quarter 2024 Financial Results
25/04/202405:02GLOBEFibroGen Announces Clinical Data from Dose Escalation Phase..
03/04/202406:46GLOBEFibroGen Announces Topline Results from Phase 1 Monotherapy..
26/03/202420:00GLOBEFibroGen to Present at 23rd Annual Needham Virtual..
11/03/202420:00GLOBEFibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer
09/03/202409:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202409:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/03/202409:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/02/202406:08EDGAR2Form 8-K - Current report
27/02/202406:06GLOBEFibroGen Reports Fourth Quarter and Full Year 2023 Financial..
27/02/202406:05GLOBEFibroGen Regains All Rights to Roxadustat from AstraZeneca..
24/02/202410:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202410:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/02/202410:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/02/202421:00GLOBEFibroGen to Report Fourth Quarter and Full Year 2023..
15/02/202405:37EDGAR2Form SC 13G - Statement of acquisition of beneficial..
06/02/202410:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/02/202421:00GLOBEFibroGen To Host Part I of Virtual KOL Investor Event Series..
25/01/202421:00GLOBEFibroGen Announces Completion of the Pamrevlumab Arm in..
27/12/202309:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202306:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202306:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202306:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202307:02GLOBEFibroGen Presents Data from Phase 3 MATTERHORN Trial of..
07/11/202306:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202306:05EDGAR2Form 8-K - Current report
07/11/202306:01GLOBEFibroGen Reports Third Quarter 2023 Financial Results
04/11/202305:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/10/202305:30EDGAR2Form 8-K - Current report
23/10/202320:00GLOBEFibroGen to Report Third Quarter 2023 Financial Results
26/09/202308:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/09/202306:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/09/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/09/202305:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/09/202305:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202309:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/09/202309:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/09/202321:55EDGAR2Form 8-K - Current report
02/09/202308:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/09/202308:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/09/202306:31EDGAR2Form 144 - Report of proposed sale of securities
30/08/202306:14EDGAR2Form 8-K - Current report
30/08/202305:15GLOBEFibroGen Announces Topline Results from LELANTOS-2, a Phase..
15/08/202306:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/08/202306:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/08/202308:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/08/202305:22EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/08/202305:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202305:06EDGAR2Form 8-K - Current report
08/08/202305:01GLOBEFibroGen Reports Second Quarter 2023 Financial Results

최근 히스토리

Delayed Upgrade Clock